Cargando…

Impact of COVID-19 pandemic in the activity of a Therapeutic Apheresis unit in Italy

INTRODUCTION: The recent Coronavirus Disease 2019 (COVID-19) outbreak has led to profound and rapid changes in the Italian and Veneto Region Healthcare System. This context also includes the quick reorganization which the Apheresis Unit (AU) of the Padova University Hospital, i.e. the Regional Refer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colpo, A., Astolfi, L., Tison, T., De Silvestro, G., Marson, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446708/ https://www.ncbi.nlm.nih.gov/pubmed/32912734 http://dx.doi.org/10.1016/j.transci.2020.102925

Ejemplares similares

Acute pancreatitis due to severe hypertriglyceridemia in the COVID-19 era: The role of therapeutic plasma exchange
por: Pavanello, Francesca, et al.
Publicado: (2022)

Apheresis and COVID-19 in intensive care unit (ICU)
por: Xanthi, Zikou, et al.
Publicado: (2022)

Apheresis and Covid-19
por: Griveas, Ioannis
Publicado: (2022)

Granulocyte Apheresis: Can It Be Associated with Anti PD-1 Therapy for Melanoma?
por: Sernicola, Alvise, et al.
Publicado: (2022)

Therapeutic apheresis in autoimmune diseases
por: Bambauer, Rolf, et al.
Publicado: (2013)

Therapeutic Apheresis in Metabolic Syndrome
por: Voinov, V.A.
Publicado: (2018)

Safety of Therapeutic Apheresis in Children and Adolescents
por: Taylan, Christina, et al.
Publicado: (2022)

Principles of Therapeutic Apheresis in Neurological Disease
por: Strasser, Erwin
Publicado: (2023)

Therapeutic apheresis in peripheral and retinal circulatory disorders
por: Ramunni, Alfonso, et al.
Publicado: (2012)

To Transplant or Not to Transplant During the SARS‐CoV‐2 Pandemic? That Is the Question
por: Marino, Dario, et al.
Publicado: (2020)

Nurse’s perspective: The effects of Covid-19 in apheresis
por: Yanchuk, Lidia, et al.
Publicado: (2020)

Therapeutic apheresis in kidney transplantation: An updated review
por: Salvadori, Maurizio, et al.
Publicado: (2019)

Therapeutic apheresis in kidney diseases: an updated review
por: Chen, Yi-Yuan, et al.
Publicado: (2022)

Polyzwitterionic Coating of Porous Adsorbents for Therapeutic Apheresis
por: Semak, Vladislav, et al.
Publicado: (2022)

Adsorptive granulocyte and monocyte apheresis: A potentially relevant therapeutic option for COVID-19
por: Kanekura, Takuro, et al.
Publicado: (2020)

Impact of COVID-19 Pandemic on Reorganization of a Rehabilitation Unit in Italy
por: Maccarone, Maria Chiara, et al.
Publicado: (2022)

LDL Apheresis and Lp (a) Apheresis: A Clinician’s Perspective
por: Kayikcioglu, Meral
Publicado: (2021)

Apheresis in Neurological Disorders
por: Dorst, Johannes
Publicado: (2020)

Role of therapeutic apheresis and phlebotomy techniques in anaesthesia and critical care
por: Bose, Neeta, et al.
Publicado: (2014)

Current Role of Lipoprotein Apheresis
por: Thompson, Gilbert, et al.
Publicado: (2019)

An academic allergy unit during COVID-19 pandemic in Italy
por: Malipiero, Giacomo, et al.
Publicado: (2020)

Application of Extracorporeal Apheresis in Treatment of COVID-19: a Rapid Review
por: Lezhnina, Arina, et al.
Publicado: (2022)

A loxoscelism case received therapeutic apheresis and hyperbaric oxygen therapy
por: Cetinkaya, Ali, et al.
Publicado: (2020)

Apheresis: A cell-based therapeutic tool for the inflammatory bowel disease
por: Yasmin, Farah, et al.
Publicado: (2022)

Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis
por: Achleitner, Martin, et al.
Publicado: (2023)

Familial Hypercholesterolemia and Lipoprotein Apheresis
por: Makino, Hisashi, et al.
Publicado: (2019)

Impact of the German Lipoprotein Apheresis Registry (DLAR) on therapeutic options to reduce increased Lp(a) levels
por: Schettler, Volker J. J., et al.
Publicado: (2015)

Apheresis of activated leukocytes with an immobilized polymyxin B filter
por: Takeyama, N, et al.
Publicado: (2010)

Activation of Lipid Mediator Formation Due to Lipoprotein Apheresis
por: Weylandt, Karsten-H., et al.
Publicado: (2019)

Pediatric unit spending in the North of Italy during the COVID-19 pandemic
por: Franceschi, Roberto, et al.
Publicado: (2023)

Seven COVID-19 Patients Treated with C-Reactive Protein (CRP) Apheresis
por: Esposito, Fabrizio, et al.
Publicado: (2022)

The impact of physical activity on psychological health during Covid-19 pandemic in Italy
por: Maugeri, Grazia, et al.
Publicado: (2020)

Transient spurious intrathecal immunoglobulin synthesis in neurological patients after therapeutic apheresis
por: Berger, Benjamin, et al.
Publicado: (2015)

Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions
por: Kleiter, Ingo, et al.
Publicado: (2018)

Reimbursement for therapeutic apheresis devices and procedures for using the healthcare insurance system in Japan
por: Kusaoi, Makio, et al.
Publicado: (2020)

Therapeutic apheresis within immune-mediated neurological disorders: dosing and its effectiveness
por: Klingele, Matthias, et al.
Publicado: (2020)

Proposal of the Need for New Korean Guidelines on the Use of Therapeutic Apheresis in Clinical Practice
por: Chung, Yousun, et al.
Publicado: (2022)

Apheresis: What Should a Clinician Know?
por: Parhofer, Klaus G.
Publicado: (2023)

LDL-Apheresis: Technical and Clinical Aspects
por: Bambauer, Rolf, et al.
Publicado: (2012)

Role of lipid apheresis in changing times
por: Schuff-Werner, Peter, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_p2r7j5m04d8a0al9cm3r1tvpuc